Literature DB >> 21047571

Epidemiology and incidence: the scope of the problem and risk factors for development of venous thromboembolism.

Paul D Stein1, Fadi Matta.   

Abstract

The proportion of hospitalized patients with pulmonary embolism (PE) is increasing. Whether this represents more admissions with PE or more diagnoses made in hospitalized patients is uncertain. The proportion of hospitalized patients with deep venous thrombosis has decreased precipitously as a result of home treatment. Asians and Native Americans have a lower incidence of PE than whites or African Americans. The incidence of PE increases exponentially with age, but no age group, including infants and children, is immune. Several medical illnesses have now been shown to be associated with a higher risk for venous thromboembolism. Epidemiologic data and new information on risk factors provide insight into making an informed clinical assessment and evaluation for antithrombotic prophylaxis.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21047571     DOI: 10.1016/j.ccm.2010.07.001

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  24 in total

1.  Neighborhood deprivation and hospitalization for venous thromboembolism in Sweden.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

Review 2.  Contraceptive care for Canadian youth.

Authors:  Giuseppina Di Meglio; Colleen Crowther; Joanne Simms
Journal:  Paediatr Child Health       Date:  2018-06-12       Impact factor: 2.253

3.  Autoimmune diseases and venous thromboembolism: a review of the literature.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

Review 4.  Bleeding risk with systemic thrombolytic therapy for pulmonary embolism: scope of the problem.

Authors:  Mitchell J Daley; Manasa S Murthy; Evan J Peterson
Journal:  Ther Adv Drug Saf       Date:  2015-04

5.  Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center.

Authors:  Atul B Shinagare; Mengye Guo; Hiroto Hatabu; Katherine M Krajewski; Katherine Andriole; Annick D Van den Abbeele; Pamela J DiPiro; Mizuki Nishino
Journal:  Cancer       Date:  2011-02-11       Impact factor: 6.860

6.  Pulmonary embolism: the weekend effect.

Authors:  Rahul Nanchal; Gagan Kumar; Amit Taneja; Jayshil Patel; Abhishek Deshmukh; Sergey Tarima; Elizabeth R Jacobs; Jeff Whittle
Journal:  Chest       Date:  2012-09       Impact factor: 9.410

7.  Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases.

Authors:  Hussain R Yusuf; W Craig Hooper; Michele G Beckman; Qing C Zhang; James Tsai; Thomas L Ortel
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

8.  Management of pulmonary embolism: state of the art treatment and emerging research.

Authors:  Omar Esponda; Alfonso Tafur
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-04

9.  Prescriber knowledge and attitudes regarding non-administration of prescribed pharmacologic venous thromboembolism prophylaxis.

Authors:  Kara L Piechowski; Stacy Elder; Leigh E Efird; Elliott R Haut; Michael B Streiff; Brandyn D Lau; Peggy S Kraus; Cynthia S Rand; Victor O Popoola; Deborah B Hobson; Norma E Farrow; Dauryne Shaffer; Kenneth M Shermock
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300

10.  Hospitalizations of adults ≥60 years of age with venous thromboembolism.

Authors:  Hussain R Yusuf; Nimia Reyes; Qing C Zhang; Ekwutosi M Okoroh; Azfar-E-Alam Siddiqi; James Tsai
Journal:  Clin Appl Thromb Hemost       Date:  2013-06-27       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.